chr14-74503992-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000428.3(LTBP2):​c.4516G>A​(p.Val1506Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00208 in 1,614,118 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 6 hom. )

Consequence

LTBP2
NM_000428.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 1.52

Publications

8 publications found
Variant links:
Genes affected
LTBP2 (HGNC:6715): (latent transforming growth factor beta binding protein 2) The protein encoded by this gene belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family possessing unique regions and with most similarity to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion. [provided by RefSeq, Jul 2008]
LTBP2 Gene-Disease associations (from GenCC):
  • glaucoma 3, primary congenital, D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Weill-Marchesani syndrome 3
    Inheritance: AR, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital glaucoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Weill-Marchesani syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glaucoma secondary to spherophakia/ectopia lentis and megalocornea
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010105163).
BS2
High Homozygotes in GnomAdExome4 at 6 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LTBP2NM_000428.3 linkc.4516G>A p.Val1506Met missense_variant Exon 31 of 36 ENST00000261978.9 NP_000419.1 Q14767

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LTBP2ENST00000261978.9 linkc.4516G>A p.Val1506Met missense_variant Exon 31 of 36 1 NM_000428.3 ENSP00000261978.4 Q14767
LTBP2ENST00000556690.5 linkc.4384G>A p.Val1462Met missense_variant Exon 30 of 35 5 ENSP00000451477.1 G3V3X5
LTBP2ENST00000553939.5 linkn.4516G>A non_coding_transcript_exon_variant Exon 31 of 36 5 ENSP00000452110.1 G3V511

Frequencies

GnomAD3 genomes
AF:
0.00149
AC:
226
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00237
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00145
AC:
364
AN:
251048
AF XY:
0.00150
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00595
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00107
Gnomad NFE exome
AF:
0.00209
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00214
AC:
3132
AN:
1461812
Hom.:
6
Cov.:
32
AF XY:
0.00203
AC XY:
1474
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33480
American (AMR)
AF:
0.000291
AC:
13
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00562
AC:
147
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000800
AC:
69
AN:
86258
European-Finnish (FIN)
AF:
0.00129
AC:
69
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00244
AC:
2710
AN:
1111998
Other (OTH)
AF:
0.00185
AC:
112
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
183
366
549
732
915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00148
AC:
226
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.00122
AC XY:
91
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41570
American (AMR)
AF:
0.000719
AC:
11
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00237
AC:
161
AN:
68030
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00196
Hom.:
0
Bravo
AF:
0.00140
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00126
AC:
153
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00196
EpiControl
AF:
0.00196

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Weill-Marchesani syndrome Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Glaucoma 3, primary congenital, D Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Weill-Marchesani syndrome 3 Uncertain:1
Aug 01, 2017
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LTBP2 NM_000428.2 exon31 p.Val1506Met (c.4516G>A): This variant has not been reported in the literature but is present in 0.2% (245/126544) of European chromosomes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs117800773). This variant is present in ClinVar (Variation ID:314272). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Glaucoma 3, primary congenital, D;C3538951:Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma;C3553785:Weill-Marchesani syndrome 3 Uncertain:1
-
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LTBP2 NM_000428.2 exon31 p.Val1506Met (c.4516G>A): This variant has not been reported in the literature but is present in 0.2% (245/126544) of European chromosomes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs117800773). This variant is present in ClinVar (Variation ID:314272). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

not provided Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LTBP2-related disorder Benign:1
Mar 09, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T;.
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.097
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.49
T;T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.010
T;T
MetaSVM
Uncertain
0.37
D
MutationAssessor
Benign
1.5
L;.
PhyloP100
1.5
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.33
N;N
REVEL
Benign
0.26
Sift
Benign
0.081
T;T
Sift4G
Benign
0.23
T;T
Polyphen
0.41
B;.
Vest4
0.37
MVP
0.71
MPC
0.19
ClinPred
0.028
T
GERP RS
5.0
Varity_R
0.048
gMVP
0.69
Mutation Taster
=73/27
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117800773; hg19: chr14-74970695; COSMIC: COSV56209721; COSMIC: COSV56209721; API